LYB vs PCSA · P/E 21, rev $16.37B vs $5.9M cap
LyondellBasell Industries NV (LYB) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
PCSA does not have a complete income-statement cache yet.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the LYB and PCSA stock pages for the full models.
Not investment advice.